Key facts
- Florida sued Pfizer and CEO Albert Bourla over COVID-19 vaccine claims.
- The lawsuit alleges Pfizer misled consumers about vaccine safety and effectiveness.
- Pfizer allegedly failed to disclose risks like heart inflammation.
- The state claims Pfizer promoted the vaccine for transmission prevention without testing it.
- Florida accuses Pfizer of unfair market dominance tactics.
- The state seeks to stop alleged conduct, fines, and return of profits.
Florida Attorney General James Uthmeier filed a lawsuit on Thursday against pharmaceutical giant Pfizer and its CEO, Albert Bourla, accusing the company of misleading consumers about the safety and effectiveness of its COVID-19 vaccine. The suit, lodged in state court, alleges that Pfizer promoted its vaccine as safe while failing to disclose potential risks, including heart inflammation and other adverse events.
The lawsuit further claims that Pfizer encouraged vaccination to protect others, despite never testing whether the vaccine prevented virus transmission. Florida also accuses the company of employing unfair tactics to maintain market dominance.
According to the state, Pfizer generated over $80 billion from vaccine sales and subsequently increased the price per dose to a range of $110 to $130 in 2023, up from $30. Florida is pursuing the case under its consumer protection law, seeking a court order to halt the alleged conduct, impose fines of $10,000 per violation (or $15,000 for harm to seniors or disabled individuals), and recover profits.
Pfizer and the Florida Attorney General's Office did not immediately respond to requests for comment.